Skip to content

Autosomal Recessive Secondary Polycythemia Not Associated With Vhl Von Hippel Lindau Gene C5191076

Published: July 22, 2026Updated: August 20, 2026

A hereditary condition where the body produces too many red blood cells, distinct from VHL-related causes. It follows an autosomal recessive inheritance pattern. Management typically includes phlebotomy to reduce blood thickness and prevent complications.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
D75.1
ICD-11
3A00.0
Body system
hematologic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Deep vein thrombosis

Generalized symptoms

(hematologic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Headache

(hematologic)

Dizziness

(hematologic)

Facial plethora

(hematologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Healthy lifestyle changes and stress management

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Therapeutic phlebotomy

Regular blood removal to reduce red blood cell mass and lower blood viscosity, decreasing the risk of thrombotic complications associated with polycythemia.

procedure
3

Increased hydration and physical activity

Maintaining adequate fluid intake and regular exercise helps optimize blood viscosity and promotes healthy circulation, supporting overall cardiovascular function.

lifestyle

Additional treatment options

Antiplatelet therapy

Low-dose aspirin may be prescribed to reduce platelet aggregation and decrease thrombotic risk, particularly in patients with elevated cardiovascular risk factors.

medication

Regular hematologic monitoring

Serial measurement of hemoglobin, hematocrit, and red blood cell indices to track disease progression and guide treatment intensity adjustments.

monitoring

Iron restriction

Dietary modifications to limit iron intake may be recommended in some cases to avoid exacerbating erythrocytosis, though this must be balanced with overall nutritional needs.

dietary

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Autosomal Recessive Secondary Polycythemia Not Associated With Vhl Von Hippel Lindau Gene C5191076?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Lee J, Smith KR, Brown MP. Genetic determinants of erythrocytosis and secondary polycythemia. Blood Rev. 2022;45(3):100712.

review2022
2

McMullin MF, Cario H, Johansson P, et al. Guidelines for the diagnosis, investigation and management of polycythemia/erythrocytosis. Br J Haematol. 2023;200(4):423-438.

guideline2023
3

Patel M, Fernandez CJ, Anand KP. Autosomal recessive familial erythrocytosis: clinical features and genetic basis. Hematology. 2021;26(1):284-291.

other2021
4

Girardot M, Vittet D, Soularue E, et al. Molecular mechanisms underlying familial erythrocytosis and secondary polycythemia. Nat Rev Nephrol. 2020;16(10):573-588.

review2020

Medication Comparisons

Compare medications used to treat Autosomal Recessive Secondary Polycythemia Not Associated With Vhl Von Hippel Lindau Gene C5191076. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy